
Promising Medication Shows Potential to Reverse Multiple Sclerosis
Scientists have used MRI scans to demonstrate the brain repair effects of clemastine, an antihistamine, in patients with multiple sclerosis (MS). The study found that clemastine increased myelin water, indicating myelin repair, even after the medication was discontinued. This innovative method of measuring myelin water fraction offers imaging-based evidence of myelin restoration and could be used to evaluate the efficacy of future therapies for MS. The findings highlight the potential for clemastine and the importance of focusing on myelin repair beyond visible lesions. Further research will explore clemastine's potential in treating myelin damage in premature infants.


